FDA & NCI Create Unique Jobs Combining Regulatory Science with Clinical Expertise July 24, 2015Vol.41 No.29By Matthew Bin Han Ong
Drugs & Targets Cleave Biosciences’s CB-5083 receives FDA orphan drug designation July 17, 2015Vol.41 No.28
Drugs & Targets FDA grants orphan drug designation to ImMucin in multiple myeloma July 17, 2015Vol.41 No.28
In Brief Georgetown Lombardi and John Theurer to Form Cancer Research Consortium July 17, 2015Vol.41 No.28
